Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Foley

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|February 1, 1983
Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicityA Kessinger, H M Lemon, J F Foley
Cancer|March 1, 1983
Therapy of malignant APUD cell tumors. Effectiveness of DTICA Kessinger, J F Foley, H M Lemon
The Nebraska Medical Journal|June 1, 1973
Carcinoma of the breast and sclerodermaA Kessinger, H M Lemon, J F Foley
Cancer Chemotherapy Reports|February 1, 1970
Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumorsJ F Foley, H M Lemon, D Miller
Cancer Treatment Reports|March 1, 1979
VM-26 as a second drug in the treatment of brain gliomasA Kessinger, H M Lemon, J F Foley
In Vitro|March 1, 1972
The infleunce of factors associated with pancreatic proteolytic enzymes on HeLa cell colonial morphologyJ F Foley, B T Aftonomos, M Heidrick
Journal of Surgical Oncology|January 1, 1977
The glucagonoma syndrome and its managementA Kessinger, H M Lemon, J F Foley
Environmental Health Perspectives|December 1, 1993
Detecting proliferating cell nuclear antigen in archival rodent tissuesA Greenwell, J F Foley, R R Maronpot
Obstetrics and Gynecology|August 1, 1976
Quadrichemotherapy for advanced ovarian carcinomaA Kessinger, J F Foley, H M Lemon
Biochimica Et Biophysica Acta|April 20, 2000
Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector couplingM Walsh, J F Foley, B T Kinsella
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|February 1, 1983
Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicityA Kessinger, H M Lemon, J F Foley
Cancer|March 1, 1983
Therapy of malignant APUD cell tumors. Effectiveness of DTICA Kessinger, J F Foley, H M Lemon
The Nebraska Medical Journal|June 1, 1973
Carcinoma of the breast and sclerodermaA Kessinger, H M Lemon, J F Foley
Cancer Chemotherapy Reports|February 1, 1970
Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumorsJ F Foley, H M Lemon, D Miller
Cancer Treatment Reports|March 1, 1979
VM-26 as a second drug in the treatment of brain gliomasA Kessinger, H M Lemon, J F Foley
In Vitro|March 1, 1972
The infleunce of factors associated with pancreatic proteolytic enzymes on HeLa cell colonial morphologyJ F Foley, B T Aftonomos, M Heidrick
Journal of Surgical Oncology|January 1, 1977
The glucagonoma syndrome and its managementA Kessinger, H M Lemon, J F Foley
Environmental Health Perspectives|December 1, 1993
Detecting proliferating cell nuclear antigen in archival rodent tissuesA Greenwell, J F Foley, R R Maronpot
Obstetrics and Gynecology|August 1, 1976
Quadrichemotherapy for advanced ovarian carcinomaA Kessinger, J F Foley, H M Lemon
Biochimica Et Biophysica Acta|April 20, 2000
Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector couplingM Walsh, J F Foley, B T Kinsella
Pageof 10